Autobahn Therapeutics, Inc.’s Post

We have a pipeline of transformative small molecule therapies to treat multiple #CNS disorders, including #majordepressivedisorder and #bipolardisorder depression. With our recent Series C financing, we are advancing these treatments in the clinic to help patients suffering with these conditions. Read more about our progress here: https://lnkd.in/gnzrDDn2

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics